Disease/Infection News

RSS

Study identifies three potential drugs to eradicate parasitic worms

Scientists have revealed a way to eradicate parasitic worms by stopping them from using alternative metabolism pathways provided by bacteria that live within them, according to new findings published today in eLife.

12 Aug 2020

SARS-CoV-2 a "swarm" of mutant viruses

In this new study, the virus was serially passaged in independent cell types in a controlled environment. The researchers found that the virus rapidly adapts to the changing conditions in culture by selecting for pre-existing species.

12 Aug 2020

Study highlights need to understand different environmental conditions that affect surface chemistry of SARS-CoV-2

Researchers at Michigan Tech, TÜV SÜD UK National Engineering Laboratory and University of Edinburgh call for increased research on virus surface stability and interaction in "Surface Chemistry Can Unlock Drivers of Surface Stability of SARS-CoV-2 in Variety of Environmental Conditions" in the Cell Press journal Chem.

12 Aug 2020

Can SARS-CoV-2 be transmitted via feces?

A new study by researchers at the University of Oxford and the Trip Medical Database and published on the preprint server medRxiv* in August 2020 as part of the ongoing Open Evidence Review on Transmission Dynamics of COVID-19 reports the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in feces and the need for precautions to prevent orofecal spread in the surroundings of confirmed or suspected cases.

12 Aug 2020

Smoking and vaping significantly increase risk of COVID-19 in teens and young adults

Now, a new study published in the Journal of Adolescent Health shows that teens and young adults may have a heightened risk of COVID-19 if they vape or smoke cigarettes. Cigarette smokers are seven times more likely to be infected with SARS-CoV-2. Meanwhile, people who vape are five times more likely to be diagnosed with the viral infection.

11 Aug 2020

Scientist explains why COVID-19 targets only some organs while others are spared

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the enzyme angiotensin-converting enzyme 2 (ACE2) to enter and infect human cells. It causes COVID-19 and can lead to a multitude of complications, including multi-organ impairment, partially due to the abundant expression of ACE2 in all human tissues.

11 Aug 2020

Focusing on human enzymes and not SARS-CoV-2 could help treat COVID-19

Now, breakthrough research into malaria suggests targeting enzymes from the human host, rather than from the pathogen itself. The new research could pave the way for effective treatments for a wide range of infectious diseases, including the coronavirus disease (COVID-19).

11 Aug 2020

Researchers uncover a new vulnerability in the novel coronavirus' infamous spike protein

Northwestern University researchers have uncovered a new vulnerability in the novel coronavirus' infamous spike protein -- illuminating a relatively simple, potential treatment pathway.

11 Aug 2020

NYC shoppers four times more likely to choose stores that follow social distancing

New York City residents are four times more likely to choose a store where shoppers respect 6 feet of distancing as opposed to one where no one is social distancing, according to an experiment by Cornell University researchers conducted using a 3D simulation.

11 Aug 2020

Natural compund in cedar and grapefruit skin could help repel mosquitoes and ticks says CDC

Over the last few years, there has been a rise in the number of cases of diseases caused by mosquito and tick bites. The U.S. Centers for Disease Control and Prevention (CDC) has said that a natural chemical compound could help combat this problem. This compound Nootkatone is found commonly in cedar trees, and grapefruit skin says the organization.

11 Aug 2020

People of color, minority groups are underrepresented in COVID-19 clinical trials

Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials, according to a new perspective authored by faculty from the University of Georgia and University of Colorado and pharmacists from Phoebe Putney Memorial Hospital in Albany.

11 Aug 2020

1st human data for Sinovac's SARS-CoV-2 CoronaVac vaccine is out

A group of Chinese researchers recently conducted a phase 2 clinical trial to further evaluate the immunogenicity and safety of SARS-CoV-2 inactivated vaccine known as CoronaVac. The results are currently available on the medRxiv preprint server and demonstrate that the vaccine is well tolerated and without any notable dose-related safety concerns, which opens the door for phase 3 clinical trial.

11 Aug 2020

Inhaled delivery of a potent neutralizing nanobody effective against SARS-CoV-2

A recent study by researchers from China, available on the bioRxiv preprint server, shows how stable neutralizing nanobody Nb11-59 might be a promising prophylactic and therapeutic molecule against coronavirus disease (COVID-19) – especially if administered via the inhalatory route.

11 Aug 2020

Study to examine possible effects of COVID-19 on dementia risk in older adults

In addition to its clear impact on physical health, COVID-19 may also have adverse consequences for brain health. Therefore, researchers at Baycrest's Rotman Research Institute (RRI) are investigating the possible effects of COVID-19 and infection prevention measures on dementia risk in older adults.

11 Aug 2020

Stanford study reveals immunological deviations and lapses in severe COVID-19 cases

Some people get really sick from COVID-19, and others don't. Nobody knows why.

11 Aug 2020

Certain N95 masks are highly effective in preventing the inhalation of airborne particles

This spring, due to limited national supplies of N95 face masks, hospitals across the country asked the public and private companies to donate personal protective equipment (PPE), including many different types of masks, to be sure healthcare workers were protected while caring for patients.

11 Aug 2020

Disease/Infection News

Study identifies three potential drugs to eradicate parasitic worms

SARS-CoV-2 a "swarm" of mutant viruses

Study highlights need to understand different environmental conditions that affect surface chemistry of SARS-CoV-2

Can SARS-CoV-2 be transmitted via feces?

Smoking and vaping significantly increase risk of COVID-19 in teens and young adults

Scientist explains why COVID-19 targets only some organs while others are spared

Focusing on human enzymes and not SARS-CoV-2 could help treat COVID-19

Researchers uncover a new vulnerability in the novel coronavirus' infamous spike protein

NYC shoppers four times more likely to choose stores that follow social distancing

Natural compund in cedar and grapefruit skin could help repel mosquitoes and ticks says CDC

People of color, minority groups are underrepresented in COVID-19 clinical trials

1st human data for Sinovac's SARS-CoV-2 CoronaVac vaccine is out

Inhaled delivery of a potent neutralizing nanobody effective against SARS-CoV-2

Study to examine possible effects of COVID-19 on dementia risk in older adults

Stanford study reveals immunological deviations and lapses in severe COVID-19 cases

Certain N95 masks are highly effective in preventing the inhalation of airborne particles

Study shows how African health services are handling disruptions caused by COVID-19

Researchers develop skin-friendly, antimicrobial wound dressing

Using medieval medicine to find new treatments for modern-day infections

Research looks at how long SARS-CoV-2 antibodies last

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News